Drug lookup
Drug reference

hepatitis b vaccine

Killed (Inactivated) viral vaccine · Vaccine for Hepatitis B

Killed (Inactivated) viral vaccineVaccine for Hepatitis B
CDSCO approved
EXCRETION
not curated
INTERACTIONS
none in our sources
PREGNANCY
not curated

Mechanism

Prepared in yeast cells by recombinant DNA technique, it contains aluminium hydroxide adsorbed hepatitis B virus surface antigen. This antigen stimulates the immune system to produce protective antibodies against the Hepatitis B virus.

Indications

Universal immunization for allPersons who come in contact with blood, blood products and other body fluids (surgeons, dentists, blood bank personnel, laboratory technicians, health care workers, haemophilics, haemodialysis patients)

Dosing

Adult
Three 1 ml injections in the deltoid muscle given at 0, 1 and 6 months.
Pediatric
Children <10 years are given 0.5 ml doses in the thigh at 0, 1 and 6 months.

Pharmacokinetics

Bioavailability
Produces protective antibody titers in 99% subjects

Related guidelines

Other Killed (Inactivated) viral vaccine drugs

Ask House about hepatitis b vaccine

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team